SCHEMBL2445186

SCHEMBL2445186

CCOc1ccc(C=NO)cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.67
ALDH1A1 P00352 6/20 0.66
SMN1; SMN2 Q16637 5/20 0.65
NPC1 O15118 4/20 0.65
RAB9A P51151 4/20 0.65
NFKB1 P19838 3/20 0.65
NFKB2 Q00653 3/20 0.65
RELA Q04206 3/20 0.65
PKM P14618 2/20 0.62
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
CYP2C19 P33261 2/20 0.62
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
HPGD P15428 3/20 0.59
MAPT P10636 3/20 0.59
HTT P42858 2/20 0.59
TSHR P16473 2/20 0.59
GAA P10253 2/20 0.57
CYP2D6 P10635 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445183 1.00 LMNA (0.67) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL12402287 0.82 GAA (0.62) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2165009 0.81 LMNA (0.59) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2165006 0.81 LMNA (0.59) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL16956820 0.81 RORC (0.50) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4940997 0.81 GAA (0.64) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL4941002 0.81 GAA (0.64) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL28969963 0.81 NPC1 (0.64) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL16774334 0.80 LMNA (1.00) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2571081 0.79 MEN1 (0.79) ALDH1A1SMN1; SMN2RAB9APKMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed